Survivin, which is an inhibitor ofapoptosis is normally highly expressed during tumor developmentand progression [40] and interestingly, the small molecule YM155 isidentified to be effective against HCC with over expression ofsurvivin [41], thus opening new therapeutic strategies. The gene discussed is BIRC5; the disease is neoplasm.